AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Source: Shutterstock
Summary
- Titan Medical stock has swelled over 600 per cent in one year, and it is currently trading at C$ 3.44 per share compared to its 52-week high of C$ 4.40.
- Empower Clinics’ market cap stands at C$ 666 million, with an astonishing one-year return of 7,000 per cent.
- Empower stocks are up over 68 per cent in the last two trading sessions.
Titan Medical Inc. (TSX:TMD) offers tempting one-year returns of over 600 per cent. The company posted revenue of C$ 20.0 million in 2020, led by development and license agreements with Medtronic plc, the US-based medical device producer.
Empower Clinics Inc. (CSE: CBDT) announced on February 18 that it tested thousands of COVID-19 samples in its diagnostics laboratory to validate its COVID-19 PCR test to detect the UK and South African mutant variants. The stock has zoomed by over 68 per cent in the last two trading sessions.
Let us delve into these two Canadian medical stocks’ performances
Titan Medical Inc. (TSX:TMD)
The company develops robotic surgical system for minimal invasive surgeries. Its stock price is C$ 3.44 per share against its 52-week high of C$ 4.40.
It has returned almost 602 per cent in one year, with a positive return on equity of 17.40 per cent.
The shares are up more than 60 per cent year-to-date (YTD), with a market cap of C$ 356.13 million.
Its cash and cash equivalents stood at C$ 25.5 million as of December 31, 2020, compared with C$ 0.8 million at the end of 2019. The medical company recorded current liabilities (except warrant liability) of C$ 6.6 million at the end of fourth quarter of 2020, against C$ 11.4 million in Q4 2019.
It held working capital of C$ 20.4 million at the end of 2020 versus a working capital deficit of C$9.7 million at the end of 2019.
Image Source: Kalkine Group @2020
Empower Clinics Inc. (CSE: CBDT)
This COVID-19 stock has been rising since announcing positive results of its PCR test against the new COVID-19 variants.
The healthcare stock surged more than 34 per cent, and 21.15 million shares exchanged hands on Friday.
On Monday morning, the stock once again took off, rocketing over 34 per cent with a volume of nearly 8.5 million. It set a new 52-week high of C$ 2.28 per cent on February 22.
The Canadian Securities Exchange-listed stock has delivered an unbelievable return of 7,000 per cent in one year. It is up as much as 710.7 per cent year-to-date, with a return on equity of 223.83 per cent.
It has a current market cap of C$ 666 million and an average trade volume of 11.31 million for the last 50 days.
